13F Pro13F Pro

FARALLON CAPITAL MANAGEMENT LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 909661
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare69.7%$11.9B
  • Technology17.9%$3.1B
  • Financials5.4%$929.5M
  • Consumer Discretionary4.9%$833.9M
  • Industrials1.5%$251.3M
  • Other0.3%$49.2M
  • Materials0.3%$44.0M
  • Energy0.0%$2.2M
  • Real Estate0.0%$226,970
  • Consumer Staples0.0%$14,250

AUM History

13fpro.ai/research/fund/farallon-capital-management-llc-909661

Conviction and streaks

Concentrating · top 10 = 55.7%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

RVMD$RVMDConviction hold14.9% weight · held 7 quartersBBIO$BBIOConviction hold4.7% weight · held 7 quartersPTGX$PTGXConviction hold4.6% weight · held 7 quartersEXEL$EXELConviction hold4.3% weight · held 7 quartersLQDA$LQDAConviction hold3.9% weight · held 7 quartersCRNX$CRNXAccumulating+89791% shares · 7 quarters runningBBIO$BBIOAccumulating+156% shares · 6 quarters runningBSX$BSXAccumulating+180% shares · 5 quarters runningGRAL$GRALAccumulating+729% shares · 4 quarters runningBIDU$BIDUAccumulating+479% shares · 3 quarters runningNTRA$NTRATrimming-54% shares · 4 quarters runningRVMD$RVMDTrimming-7% shares · 3 quarters runningAMZN$AMZNTrimming-42% shares · 2 quarters runningAON$AONTrimming-48% shares · 2 quarters runningWAB$WABTrimming-64% shares · 2 quarters running

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/farallon-capital-management-llc-909661

FARALLON CAPITAL MANAGEMENT LLC 13F holdings — Q2 2026

$21.7B portfolio (+23.6% QoQ) · 89 holdings · Q2 2026 13F · top 10 are 56% of the stock portfolio

Includes $4.6B of put/call options ($4.6B puts, $28.4M calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $17.1B. Weights use the stock portfolio.

All holdings — FARALLON CAPITAL MANAGEMENT LLC (Q2 2026)

89 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
SPY$SPYPUTSPDR S&P 500 ETF TRUST$4.5B+161%
TMO$TMOTHERMO FISHER SCIENTIFIC INC.$526.0M+19%
ROIV$ROIVRoivant Sciences Ltd.$506.4M+48%
AON$AONAon plc$458.6M-45%
BSX$BSXBOSTON SCIENTIFIC CORP$449.0M+41%
AVGO$AVGOBroadcom Inc.$435.1M-35%
MSFT$MSFTMICROSOFT CORP$415.1M-53%
TNGX$TNGXTango Therapeutics, Inc.$383.8M+35%
KKR$KKRKKR & Co. Inc.$378.0M-12%
SNPS$SNPSSYNOPSYS INC$370.1M-32%
BEAM$BEAMBeam Therapeutics Inc.$351.3M+1%
CRNX$CRNXCrinetics Pharmaceuticals, Inc.$336.4M+8%
GRAL$GRALGRAIL, Inc.$284.1M+28%
WAB$WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP$241.2M-44%
IMVT$IMVTImmunovant, Inc.$223.7M+275%

What changed in Q2 2026

Against the previous quarter's 13F: 21 new, 30 added to, 23 trimmed, 105 sold out. Share-count changes; largest moves by dollar size first.

New positions (21)

  • EA$EAELECTRONIC ARTS INC.$1.6B

    first bought this quarter

  • PUTISHARES TR - ISHARES SEMICDTR$83.3M

    first bought this quarter

  • PBLS$PBLSParabilis Medicines, Inc.$64.8M

    first bought this quarter

  • NVS$NVSNOVARTIS AG$56.9M

    first bought this quarter

  • WRBY$WRBYWarby Parker Inc.$25.1M

    first bought this quarter

  • KLRA$KLRAKailera Therapeutics, Inc.$24.2M

    first bought this quarter

+15 more in the Excel export

Added to (30)

  • SPY$SPYPUTSPDR S&P 500 ETF TRUST+161%

    now $4.5B

  • IMVT$IMVTImmunovant, Inc.+275%

    now $223.7M · held 7+ qtrs, 2 adds in a row

  • ROIV$ROIVRoivant Sciences Ltd.+48%

    now $506.4M · held 7+ qtrs, 2 adds in a row

  • BSX$BSXBOSTON SCIENTIFIC CORP+41%

    now $449.0M · held 7+ qtrs

  • BBIO$BBIOBridgeBio Pharma, Inc.+15%

    now $800.1M · held 7+ qtrs, 6 adds in a row

  • TNGX$TNGXTango Therapeutics, Inc.+35%

    now $383.8M · held 7+ qtrs

+24 more in the Excel export

Trimmed (23)

  • MSFT$MSFTMICROSOFT CORP-53%

    now $415.1M · held 7+ qtrs

  • AMZN$AMZNAMAZON COM INC-38%

    now $627.5M · held 5 qtrs, 2 trims in a row

  • AON$AONAon plc-45%

    now $458.6M · held 7+ qtrs, 2 trims in a row

  • NTRA$NTRANatera, Inc.-31%

    now $602.2M · held 7+ qtrs, 4 trims in a row

  • AVGO$AVGOBroadcom Inc.-35%

    now $435.1M · held 3 qtrs

  • UNH$UNHUNITEDHEALTH GROUP INC-30%

    now $528.1M · held 7+ qtrs

+17 more in the Excel export

Sold out (105)

  • PUTINVESCO EXCHANGE TRADED FD Twas $690.9M
  • SCHW$SCHWSCHWAB CHARLES CORPwas $371.8M

    held 6+ qtrs

  • GOOG$GOOGAlphabet Inc.was $285.8M

    held 6+ qtrs

  • V$VVISA INC.was $254.1M

    held 6+ qtrs

  • DIS$DISWalt Disney Cowas $231.5M

    held 6+ qtrs

  • MA$MAMastercard Incwas $217.4M

    held 6+ qtrs

+99 more in the Excel export

Firm AUM (Form ADV): $52.1B as of 2025-12-31 · SEC IAPD

Share

Holdings by quarter

Every 13F FARALLON CAPITAL MANAGEMENT LLC has filed, 13 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow FARALLON CAPITAL MANAGEMENT?

Q2 2026 13F filed with the SEC on Aug 14, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of FARALLON CAPITAL MANAGEMENT's top 20 holdings: 58/100 (our AI quality score, weighted by position size; 17 of the 20 are scored)

Top 10 since filing

-4.5%

Value-weighted move of the 10 largest stock positions

Turnover

21%

Last quarter; 72% over the last 4

Top 10 weight

56%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

78%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

FARALLON CAPITAL MANAGEMENT LLC disclosed 89 positions worth $21.7B in its Form 13F-HR for Q2 2026 — $17.1B in common stock plus $4.6B of put/call option positions (reported at underlying notional value, not premium at risk), led by $RVMD (Revolution Medicines, Inc.) at 14.9% of the equity portfolio, followed by $EA and $BBIO. During the quarter the fund opened 21 new positions and exited 105 — including a new stake in $EA. The portfolio is most concentrated in Healthcare (69.7% of disclosed assets). All figures are sourced directly from FARALLON CAPITAL MANAGEMENT LLC’s Form 13F-HR filing with the SEC under CIK 909661.

Funds like this

managers whose biggest positions overlap FARALLON CAPITAL MANAGEMENT's
Caligan Partners LP$2.13B 13F book · 6 shared top holdingsRVMDEXELLQDATNGXBAKER BROS. ADVISORS LP$19.96B 13F book · 5 shared top holdingsRVMDGRALIMVTROIVIntegral Health Asset Management, LLC$2.53B 13F book · 9 shared top holdingsRVMDROIVBSXTNGXParadigm Biocapital Advisors LP$5.34B 13F book · 3 shared top holdingsRVMDTNGXASMBCasdin Capital, LLC$2.00B 13F book · 5 shared top holdingsRVMDBEAMGRALPBLSDEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)$9.59B 13F book · 5 shared top holdingsRVMDTNGXLNTHACHC

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: FARALLON CAPITAL MANAGEMENT LLC

13F Pro is an AI hedge fund tracker and stock research platform. For FARALLON CAPITAL MANAGEMENT LLC (SEC CIK: 909661), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in FARALLON CAPITAL MANAGEMENT LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.